Table 3

Comparison of GeneXpert TV assay results in symptomatic and asymptomatic women compared with a patient-infected status of culture and/or a NAAT assay

Sample typeStatusTotal (n)SensSpecPrev (%)PPV (%)NPV (%)
ESSymp685100% (71/71)98.5% (605/614)10.488.8100
Asymp111498.1% (104/106)99.1% (999/1008)9.592.099.8
Overall179998.9% (175/177)*98.9% (1604/1622)†9.890.799.9
Differencep Valuep=0.517p=0.331
PC-VSSymp68298.6% (73/74)99.5% (605/608)10.996.199.8
Asymp110995.0% (113/119)99.6% (986/990)10.796.699.4
Overall179196.4% (186/193)‡99.6% (1591/1598)§10.896.499.6
Differencep Valuep=0.254p=1.000
URSymp68898.6% (71/72)99.8% (615/616)10.598.699.8
Asymp110598.2% (109/111)99.6% (990/994)10.096.599.8
Overall179398.4% (180/183)¶99.7% (1605/1610)**10.297.399.8
Differencep Valuep=1.000p=0.655
  • *Testing results by sequencing: 1 of 2 FN was TV positive; 1 of 2 was TV negative.

  • †Testing results by sequencing: 8 of 18 FP were TV positive; 10 of 18 were TV negative.

  • ‡Testing results by sequencing: 3 of 7 FN were TV positive; 4 of 7 were TV negative.

  • §Testing results by sequencing: 5 of 7 FP were TV positive; 2 of 7 were TV negative.

  • ¶Testing results by sequencing: 3 of 3 FN were TV negative.

  • **Testing results by sequencing: 5 of 5 FP were TV negative.

  • ES, endocervical swab; NAAT, nucleic acid amplification test; PC-VS, patient-collected vaginal swab; UR, urine.